JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

148.21

+0.39%↑

Начало・Списък с акции・Waters Corp

Waters Corp

Затворен

СекторЗдравеопазване

359.39 1.09

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

357.33

Максимум

359.55

Ключови измерители
By Trading Economics
Приходи	26M 147M
Продажби	110M 771M
P/E Средно за сектора	30.21 37.461
EPS	2.95
Марж на печалбата	19.072
Служители	7,600
EBITDA	92M 244M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+2.09% upside

Дивиденти
By Dow Jones
Следващи печалби	4.11.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	3.4B 20B
Предишно отваряне	358.3
Предишно затваряне	359.39

Настроения в новините

By Acuity

45%

55%

128 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

345.22 / 351.01 Подкрепа & съпротива

Waters Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.07.2025 г., 14:26 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14.07.2025 г., 11:08 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15.07.2025 г., 18:32 ч. UTC

Придобивния, сливания и поглъщания

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15.07.2025 г., 18:31 ч. UTC

Придобивния, сливания и поглъщания

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14.07.2025 г., 16:53 ч. UTC

Горещи акции

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14.07.2025 г., 16:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14.07.2025 г., 15:06 ч. UTC

Придобивния, сливания и поглъщания

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14.07.2025 г., 14:11 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14.07.2025 г., 10:53 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14.07.2025 г., 10:22 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14.07.2025 г., 10:22 ч. UTC

Придобивния, сливания и поглъщания

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14.07.2025 г., 10:22 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14.07.2025 г., 10:21 ч. UTC

Придобивния, сливания и поглъщания

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14.07.2025 г., 10:20 ч. UTC

Придобивния, сливания и поглъщания

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14.07.2025 г., 10:19 ч. UTC

Придобивния, сливания и поглъщания

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14.07.2025 г., 10:19 ч. UTC

Придобивния, сливания и поглъщания

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14.07.2025 г., 10:18 ч. UTC

Придобивния, сливания и поглъщания

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14.07.2025 г., 10:18 ч. UTC

Придобивния, сливания и поглъщания

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14.07.2025 г., 10:17 ч. UTC

Придобивния, сливания и поглъщания

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14.07.2025 г., 10:16 ч. UTC

Придобивния, сливания и поглъщания

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14.07.2025 г., 10:16 ч. UTC

Придобивния, сливания и поглъщания

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14.07.2025 г., 10:15 ч. UTC

Придобивния, сливания и поглъщания

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14.07.2025 г., 10:15 ч. UTC

Придобивния, сливания и поглъщания

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Сравнение с други в отрасъла

Ценова промяна

Waters Corp Прогноза

Ценова цел

By TipRanks

2.09% нагоре

12-месечна прогноза

Среден 367 USD 2.09%

Висок 465 USD

Нисък 315 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за Waters Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

Купи

Задържане

Продай

Според 13 анализатори, дали борсови рейтинги на Waters Corp през последните 3 месеца.

Техническа оценка

By Trading Central

345.22 / 351.01Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Настроение

By Acuity

128 / 371 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.